Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01801124 · ClinicalTrials.gov registry record · Phase 4
EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair
A Phase 4 study, sponsored by Pacira Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 13
- Enrollment target
NCT01801124 is a Phase 4 study that has completed, run by Pacira Pharmaceuticals. The registered enrollment target is 13 participants.
The verdict
NCT01801124, a Phase 4 study, has completed, sponsored by Pacira Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 13 participants
- Enrollment target
Study Summary
Phase 4 study evaluating the effectiveness of EXPAREL when infiltrated into the the Transversus Abdominis Plane (TAP).
Interventions
- DRUG EXPAREL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01801124
The ClinicalTrials.gov registry entry for NCT01801124 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pacira Pharmaceuticals, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EXPAREL is the first listed.
NCT01801124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01801124 about?
NCT01801124 is a clinical study titled "EXPAREL Infiltrated Into the TAP for Postoperative Analgesia in Unilateral Abdominal Hernia Repair". Phase 4 study evaluating the effectiveness of EXPAREL when infiltrated into the the Transversus Abdominis Plane (TAP).
What is the current status of trial NCT01801124?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 13 participants. The study started on 2012-04. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01801124?
The interventions under investigation include: EXPAREL (DRUG).
Who is sponsoring clinical trial NCT01801124?
This trial is sponsored by Pacira Pharmaceuticals, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.